GERON CORPORATION

GERN US3741631036

🆔
Registration No.
2247797
💰
Capitalization
Small-cap

Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.

🔗
Website
Annual Insiders Turnover, USD 2

1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);

Insider Activity
📊
Transactions
11
🙍
Insiders
7
Person Price Shares Total Published Completed
Lawlis V Bryan
 1.18
USD 		13,300
Bought 		15,667
USD 		09/05/2025 09/05/2025
Lawlis V Bryan
 1.18
USD 		13,300
Bought 		15,667
USD 		09/05/2025 09/05/2025
Lawlis V Bryan
 1.18
USD 		13,300
Bought 		15,667
USD 		09/05/2025 09/05/2025
Ziegler James
EX VP 		1.60
USD 		100,000
Bought 		160,000
USD 		27/02/2025 27/02/2025
Scarlett John A
CEO 		1.77
USD 		12,500
Bought 		22,063
USD 		27/02/2025 27/02/2025
Samuels Scott Alan
EX VP 		1.61
USD 		15,000
Bought 		24,150
USD 		27/02/2025 27/02/2025
Grethlein Andrew J
EX VP 		4.56
USD 		674,348
Sold 		3,073,004
USD 		08/07/2024 08/07/2024
Feller Faye
CMO 		4.63
USD 		287,900
Sold 		1,334,129
USD 		10/06/2024 10/06/2024
Kapur Anil
CCO 		4.65
USD 		421,875
Sold 		1,959,609
USD 		10/06/2024 10/06/2024
Scarlett John A
CEO 		4.00
USD 		600,000
Sold 		2,400,000
USD 		04/06/2024 04/06/2024

Integrated EOD Stock Data and Insider Transactions Chart

Sign in or subscribe to include GERON CORPORATION to your watchlist and receive automatic alerts for upcoming transactions.

The visibility of insider buy and sell transactions on this chart should not be the sole factor in your decision to buy or sell a particular stock. Always consider the following dynamic reports for a broader understanding of stock market activities:

 

Last 52W Low 52W High All-Time Low All-Time High β
Company Insiders
Person / Entity Transactions Turnover, USD Average, USD First Last
Grethlein Andrew J 1 3,073,003.84 3,073,003.84 08/07/2024 08/07/2024
Scarlett John A 2 2,422,062.50 1,211,031.25 04/06/2024 27/02/2025
Kapur Anil 1 1,959,609.37 1,959,609.37 10/06/2024 10/06/2024
Feller Faye 1 1,334,128.60 1,334,128.60 10/06/2024 10/06/2024
Lawlis V Bryan 4 178,252.20 44,563.05 15/05/2024 09/05/2025
Ziegler James 1 160,000.00 160,000.00 27/02/2025 27/02/2025
Samuels Scott Alan 1 24,150.00 24,150.00 27/02/2025 27/02/2025

Insiders marked in yellow represent long-term insiders. These are individuals who have engaged in transactions for over 3 years and have conducted at least 10 transactions or reached a cumulative turnover of $1M USD. When examining transaction clusters, we prioritize those conducted by long-term insiders for analysis.

Stock Advanced Metrics
Delta Correlation subscribe 🔒
Upper Bound of Standardized Transaction Amount (ubsta), USD 4 subscribe 🔒

4 represents the maximum expected transaction amount for a company's insiders, calculated based on historical data. It provides insight into the typical range of insider transaction amounts and helps in identifying unusually large transactions.

5 a proprietary metric reflecting the consistency of insider trading behavior within a company. A higher discipline index suggests more regular and predictable insider transactions.